MedWatch

Demant owner's GN investment could draw attention of competition authority, says law professor

Though not yet problematic, William Demant Invest’s share purchases in GN Group could draw the eye of officials if the investment continues to get bigger.

Photo: Demant / PR

Nothing is stopping William Demant Invest, majority owner of hearing aid manufacturer Demant, from continuing to buy up GN Shares – that is, as long as the investment firm stops before gaining full control of the company when it comes to voting power.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs